Collegium Pharmaceutical, Inc. · 2 days ago
Therapeutic Specialist, Pain - Orlando
Collegium Pharmaceutical is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Therapeutic Specialist, Pain, will be responsible for implementing Collegium’s sales/marketing plan to assure maximum market penetration and developing relationships with target Health Care Professionals to promote responsible pain management.
BiotechnologyLife ScienceMedicalTherapeutics
Responsibilities
Seek and foster strong business relationships with health care partners and customers
Develop plan to meet with target customers in assigned territory and serve as a clinical resource for customers
Organize and execute sales presentations
Knowledgeable of the competition's products, service offerings, and activity
Deliver product fair balance information to appropriate customers effectively
Plan and execute effective call plan
Increase Collegium product portfolio market share
Uphold and consistently demonstrate Collegium’s Core Values
Be accountable for delivery of quality work on time and with minimal errors
Explain information related to own output
Work on problems and ideas of some complexity with defined guidelines
Continue to increase depth of understanding of job
Manage self but beginning to operate with some independence
Qualification
Required
Bachelor's degree required
2-4 years of Pharmaceutical/Life Science industry experience required
Proficiency with Microsoft Office (Excel, Outlook, PowerPoint, Word) required
Preferred
Proven success in an entrepreneurial environment preferred
Company
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical is building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions.
Funding
Current Stage
Public CompanyTotal Funding
$1.29BKey Investors
TPG BiotechNational Institute on Drug Abuse (NIDA)Frazier Healthcare Partners
2025-12-30Post Ipo Debt· $980M
2023-02-07Post Ipo Debt· $203.2M
2015-05-07IPO
Recent News
2026-01-16
2026-01-09
MarketScreener
2025-12-31
Company data provided by crunchbase